These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 24547721)

  • 21. Drug-induced lupus: an update on its dermatologic aspects.
    Marzano AV; Vezzoli P; Crosti C
    Lupus; 2009 Oct; 18(11):935-40. PubMed ID: 19762393
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical, histologic, and immunofluorescent distinctions between subacute cutaneous lupus erythematosus and discoid lupus erythematosus.
    David-Bajar KM; Bennion SD; DeSpain JD; Golitz LE; Lee LA
    J Invest Dermatol; 1992 Sep; 99(3):251-7. PubMed ID: 1512459
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Study of cross reactivity between proton pump inhibitors].
    Hammami S; Affes H; Ksouda K; Feki M; Sahnoun Z; Zeghal KM
    Therapie; 2013; 68(6):361-8. PubMed ID: 24356187
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Drug-induced subacute cutaneous lupus erythematosus related to doxycycline.
    Miller KK; Chu J; Patel R; Kamino H
    Dermatol Online J; 2011 Oct; 17(10):3. PubMed ID: 22031629
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Subacute cutaneous lupus erythematosus induced by chemotherapy: gemcitabine as a causative agent.
    Wiznia LE; Subtil A; Choi JN
    JAMA Dermatol; 2013 Sep; 149(9):1071-5. PubMed ID: 23842655
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A difficult diagnosis: drug-induced subacute cutaneous lupus erythematosus (SCLE) triggered by omeprazole in a patient with pre-existing idiopathic SCLE.
    Wee JS; Natkunarajah J; Marsden RA
    Clin Exp Dermatol; 2012 Jun; 37(4):445-6. PubMed ID: 22420369
    [No Abstract]   [Full Text] [Related]  

  • 27. The cutaneous pathology associated with seropositivity for antibodies to SSA (Ro): a clinicopathologic study of 23 adult patients without subacute cutaneous lupus erythematosus.
    Magro CM; Crowson AN
    Am J Dermatopathol; 1999 Apr; 21(2):129-37. PubMed ID: 10218672
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Are there distinct clinical and pathological features distinguishing idiopathic from drug-induced subacute cutaneous lupus erythematosus? A European retrospective multicenter study.
    Guicciardi F; Atzori L; Marzano AV; Tavecchio S; Girolomoni G; Colato C; Villani AP; Kanitakis J; Mitteldorf C; Satta R; Cribier B; Gusdorf L; Rossi MT; Calzavara-Pinton P; Bielsa I; Fernandez-Figueras MT; Kempf W; Filosa G; Pilloni L; Rongioletti F
    J Am Acad Dermatol; 2019 Aug; 81(2):403-411. PubMed ID: 30763648
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Subacute cutaneous lupus erythematosus as a rare complication of disease-modifying therapy administration in multiple sclerosis: case report.
    Xu K; Zhang M; Yang S; Yu G; Zheng P; Qin X; Feng J
    BMC Neurol; 2023 Apr; 23(1):168. PubMed ID: 37101279
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Subacute cutaneous lupus erythematosus lesions precipitated by griseofulvin.
    Miyagawa S; Okuchi T; Shiomi Y; Sakamoto K
    J Am Acad Dermatol; 1989 Aug; 21(2 Pt 2):343-6. PubMed ID: 2474012
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Golimumab-exacerbated subacute cutaneous lupus erythematosus.
    Wilkerson E; Hazey MA; Bahrami S; Callen JP
    Arch Dermatol; 2012 Oct; 148(10):1186-90. PubMed ID: 23069957
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Drug-induced lupus erythematosus.
    Marzano AV; Tavecchio S; Menicanti C; Crosti C
    G Ital Dermatol Venereol; 2014 Jun; 149(3):301-9. PubMed ID: 24819757
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Subacute cutaneous lupus erythematosus induced by terbinafine].
    Amitay-Layish I; Feuerman H; David M
    Harefuah; 2006 Jul; 145(7):480-2, 552. PubMed ID: 16900733
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Subacute cutaneous lupus erythematosus with positive anti-Ro antibodies following palbociclib and letrozole treatment: A case report and literature review.
    Russell-Goldman E; Nazarian RM
    J Cutan Pathol; 2020 Jul; 47(7):654-658. PubMed ID: 32119141
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Subacute cutaneous lupus erythematosus versus systemic lupus erythematosus: diagnostic criteria and therapeutic implications.
    Chlebus E; Wolska H; Blaszczyk M; Jablonska S
    J Am Acad Dermatol; 1998 Mar; 38(3):405-12. PubMed ID: 9520021
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Drug-induced anti-Ro positive subacute cutaneous lupus in a man treated with olmesartan.
    Gray T; Segars K; Farsi M; Ross R; Miller R
    Dermatol Online J; 2019 Dec; 25(12):. PubMed ID: 32045161
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Subacute cutaneous lupus erythematosus presenting as poikiloderma.
    Hughes R; Loftus B; Kirby B
    Clin Exp Dermatol; 2009 Dec; 34(8):e859-61. PubMed ID: 20055848
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Drug-induced subacute cutaneous lupus erythematosus: a paradigm for bedside-to-bench patient-oriented translational clinical investigation.
    Sontheimer RD; Henderson CL; Grau RH
    Arch Dermatol Res; 2009 Jan; 301(1):65-70. PubMed ID: 18797894
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Subacute cutaneous lupus erythematosus associated with radioiodine treatment.
    Abbott RA; May K; Motley RJ
    Clin Exp Dermatol; 2012 Oct; 37(7):753-4. PubMed ID: 22369225
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lichenoid and subacute cutaneous lupus erythematosus-like dermatitis associated with antihistamine therapy.
    Crowson AN; Magro CM
    J Cutan Pathol; 1999 Feb; 26(2):95-9. PubMed ID: 10082400
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.